Clinical trial
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage…
NCT00003596 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003596 |
|---|---|
| Title | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer |
| Official title | A Phase III Randomized Study of 5-Fluorouracil, Mitomycin-C, and Radiotherapy Versus 5-Fluorouracil, Cisplatin, and Radiotherapy in Carcinoma of the Anal Canal |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group Cancer and Leukemia Group B SWOG Cancer Research Network North Central Cancer Treatment Group |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anal Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, fluorouracil, mitomycin C, radiation therapy |
| Enrollment | 682 |
| Start date | Oct 1, 1998 |
| Primary completion | Oct 1, 2005 |
| Completion | Dec 1, 2016 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 4, 2017 |
| Countries | South Africa, United States |
At a glance
- 100–999 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: